U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H9NO3
Molecular Weight 119.1192
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THREONINE

SMILES

C[C@@H](O)[C@H](N)C(O)=O

InChI

InChIKey=AYFVYJQAPQTCCC-GBXIJSLDSA-N
InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/8296531 | https://www.ncbi.nlm.nih.gov/pubmed/1905383 | https://www.ncbi.nlm.nih.gov/pubmed/12523390

L-threonine is an essential amino acid. Threonine is a precursor of glycine. The biochemical studies on rats proved that glycine is synthesized from threonine (through threonine dehydrogenase pathway). Threonine dehydrogenase is the key enzyme in mammals like pigs, cat, and rats for degradation of 80% threonine. In adult humans, degradation of 7–11% of threonine is done by threonine dehydrogenase. The human L-threonine 3-dehydrogenase gene (GeneID: 157739, UniProtKB: Q8IZJ6 (TDH_HUMAN)) is an expressed pseudogene having lost the splice acceptor site preceding exon 6 and codon arginine-214 (CGA) is mutated to a stop codon (TGA). A few trials demonstrated that oral L-threonine may alleviate clinical signs of amyotrophic lateral sclerosis and spasticity in humans. L-Threonine has recently been brought into agricultural industry for balancing the livestock feed.

Originator

Curator's Comment: reference retrieved from http://www.jbc.org/content/115/3/721.full.pdf

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
FREAMINE III 10%

Approved Use

Parenteral nutrition with 8.5% FreAmine® III (Amino Acid Injection) with Electrolytes is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and pediatric patients, where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. Dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance

Launch Date

1971
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
200 μM
15 mg/kg single, intravenous
dose: 15 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
THREONINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
300 μg × h/mL
15 mg/kg single, intravenous
dose: 15 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
THREONINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1 h
15 mg/kg single, intravenous
dose: 15 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
THREONINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.
2001
The first constant-domain (CH1) exon of human IGHG2 is polymorphic and in strong linkage disequilibrium with the CH2 exon polymorphism encoding the G2m(n+) allotype in Caucasians.
2001
Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.
2001
A single amino-acid in the TM1 domain is an important determinant of the desensitization kinetics of recombinant human and guinea pig alpha-homomeric 5-hydroxytryptamine type 3 receptors.
2001 Apr
Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors.
2001 Apr
Phosphoserine/threonine-binding domains.
2001 Apr
Starvation-induced lysosomal degradation of aldolase B requires glutamine 111 in a signal sequence for chaperone-mediated transport.
2001 Apr
F X Nottingham and F X Taunton. Two novel mutations in factor X resulting in loss of functional activity and an interpretation using molecular modelling.
2001 Feb
Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers.
2001 Feb
Tyrosine phosphorylation of p120(ctn) in v-Src transfected L cells depends on its association with E-cadherin and reduces adhesion activity.
2001 Feb
Molecular interactions between the specialist herbivore Manduca sexta (Lepidoptera, Sphingidae) and its natural host Nicotiana attenuata. II. Accumulation of plant mRNAs in response to insect-derived cues.
2001 Feb
Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
2001 Feb 1
Electrophysiologic endpoint measures in a multicenter ALS drug trial.
2001 Feb 15
The ATP-dependent CodWX (HslVU) protease in Bacillus subtilis is an N-terminal serine protease.
2001 Feb 15
LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505.
2001 Feb 15
Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells.
2001 Feb 2
Role of Thr(11) in the binding of omega-conotoxin MVIIC to N-type Ca2+ channels.
2001 Feb 23
Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors.
2001 Feb 27
Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting.
2001 Feb 8
Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356.
2001 Feb 9
Thr226 is a key residue for bioluminescence spectra determination in beetle luciferases.
2001 Feb 9
Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta.
2001 Jan
Rapid deposition of wheat cell wall structural proteins in response to Fusarium-derived elicitors.
2001 Jan
Near-infrared reflectance spectroscopy enables the fast and accurate prediction of the essential amino acid contents in soy, rapeseed meal, sunflower meal, peas, fishmeal, meat meal products, and poultry meal.
2001 Jan
Identification of tyrosine-phosphorylated proteins associated with the nuclear envelope.
2001 Jan
An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease.
2001 Jan
FMN is covalently attached to a threonine residue in the NqrB and NqrC subunits of Na(+)-translocating NADH-quinone reductase from Vibrio alginolyticus.
2001 Jan 12
Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.
2001 Jan 15
Serotonin activates S6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes.
2001 Jan 15
Follicle-stimulating-hormone receptor and twinning.
2001 Jan 20
A molecular marker for chloroquine-resistant falciparum malaria.
2001 Jan 25
Protein control of the redox potential of the primary quinone acceptor in reactioncCenters from Rhodobacter sphaeroides.
2001 Jan 30
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
2001 Jan 4
Electrical activity regulates AChR gene expression via JNK, PKCzeta and Sp1 in skeletal chick muscle.
2001 Jan 5
Phase-feeding supports maximum growth performance of broiler chicks from forty-three to seventy-one days of age.
2001 Mar
Studies on feeding peanut meal as a protein source for broiler chickens.
2001 Mar
A novel mechanism controls anaerobic and catabolite regulation of the Escherichia coli tdc operon.
2001 Mar
Biochemical characterization of cholesterol-3-sulfate as the sole effector for the phosphorylation of HMG1 by casein kinase I in vitro.
2001 Mar
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
2001 Mar
Isolation and characterisation of genomic and cDNA clones coding for a serine-, alanine-, and proline-rich protein of Trypanosoma cruzi.
2001 Mar
Three-dimensional structure of human follicle-stimulating hormone.
2001 Mar
Topology and structure of the C1q-binding site on C-reactive protein.
2001 Mar 15
Hydrophobic analogues of the winter flounder 'antifreeze' protein.
2001 Mar 2
Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.
2001 Mar 6
Expression and mutagenesis of the NqrC subunit of the NQR respiratory Na(+) pump from Vibrio cholerae with covalently attached FMN.
2001 Mar 9
The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
2001 Mar 9
Phosphorylation-dependent conformation and proteolytic stability of c-Myb.
2001 Mar-Apr
Sodium-substrate cotransport in bacteria.
2001 May 1
Recent progress in the Na(+)-translocating NADH-quinone reductase from the marine Vibrio alginolyticus.
2001 May 1
Synthesis of bisaminoacylated pdCpAs and tandemly activated transfer RNAs.
2007 Jul 1
Patents

Sample Use Guides

L-threonine (4 g daily) with pyridoxal phosphate (160 mg daily) for six months in patients with amyotrophic lateral sclerosis. Threonine supplementation (500 mg/day) was given to 6 patients with genetic spasticity syndromes for a period of 12 months, followed by a 4-month observation period without medication. Oral L-threonine at 6 g/day in patients with spinal spasticity.
Route of Administration: Oral
20 mM L-Threonine increases heat shock protein (HSP)70 and HSP25 expression and protects intestinal epithelial cells from heat stress injury
Name Type Language
THREONINE
EP   HSDB   II   INCI   INN   MART.   MI   USAN   USP   VANDF   WHO-DD  
USAN   INCI   INN  
Official Name English
THREONINE, L-
Systematic Name English
THREONINE [MART.]
Common Name English
THREONINE [MI]
Common Name English
(2S,3R)-2-AMINO-3-HYDROXYBUTYRIC ACID
Systematic Name English
NSC-46701
Code English
Threonine [WHO-DD]
Common Name English
THREONINE [USP MONOGRAPH]
Common Name English
L-THREONINE [JAN]
Common Name English
THREONINE [EP MONOGRAPH]
Common Name English
THREONINE [II]
Common Name English
NSC-16589
Code English
(R-(R*,S*))-2-AMINO-3-HYDROXYBUTANOIC ACID
Systematic Name English
THREONINE [INCI]
Common Name English
L-THREONINE [FCC]
Common Name English
LYSINE HYDROCHLORIDE IMPURITY C [EP IMPURITY]
Common Name English
FEMA NO. 4710
Code English
THREONINE [HSDB]
Common Name English
THREONINE [VANDF]
Common Name English
(S)-THREONINE
Systematic Name English
L-THREONINE [USP-RS]
Common Name English
threonine [INN]
Common Name English
THREONINE [USAN]
Common Name English
L-THREONINE
FCC   USP-RS  
Systematic Name English
THR
Common Name English
Classification Tree Code System Code
LOINC 3010-6
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47788-5
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 27179-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 32272-7
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47789-3
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 3009-8
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 44413-3
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 20658-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
NCI_THESAURUS C68442
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 30057-4
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47785-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 3008-0
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 3007-2
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
JECFA EVALUATION L-THREONINE
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
FDA ORPHAN DRUG 62191
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 25988-7
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 13416-3
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 27322-7
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 22688-6
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 13815-6
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 26897-9
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
FDA ORPHAN DRUG 33888
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
CFR 21 CFR 172.320
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 15144-9
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 25540-6
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
DSLD 167 (Number of products:18)
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 32273-5
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 3006-4
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 22740-5
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 25989-5
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47784-4
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 22643-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
DSLD 2066 (Number of products:732)
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 17704-8
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47790-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47786-9
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 47787-7
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 15134-0
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
LOINC 56641-4
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
Code System Code Type Description
JECFA MONOGRAPH
2096
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
NSC
46701
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
EPA CompTox
DTXSID2046412
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
DRUG BANK
DB00156
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
CHEBI
57926
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
RS_ITEM_NUM
1667202
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
CHEBI
26986
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
RXCUI
10524
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY RxNorm
INN
6172
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
WIKIPEDIA
THREONINE
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
MERCK INDEX
m10804
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
200-774-1
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
FDA UNII
2ZD004190S
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
CHEBI
30013
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
PUBCHEM
6288
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
DRUG CENTRAL
4254
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
MESH
D013912
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
EVMPD
SUB10989MIG
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
DAILYMED
2ZD004190S
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
SMS_ID
100000092365
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
CHEBI
16857
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
NCI_THESAURUS
C29602
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
EVMPD
SUB21991
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
CAS
72-19-5
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
ChEMBL
CHEMBL291747
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
NSC
16589
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY
HSDB
7797
Created by admin on Sat Dec 16 17:51:52 GMT 2023 , Edited by admin on Sat Dec 16 17:51:52 GMT 2023
PRIMARY